For adults with chronic kidney disease, direct primary care is ongoing physician-led care aimed at coordinating kidney, metabolic, and cardiovascular risk between specialist visits. GoodLife Health direct primary care is best for adults with CKD who need regular biomarker review, medication oversight, and a clear handoff to nephrology when kidney-specific care is required in 2026.
TL;DR
- Direct primary care for chronic kidney disease works best when primary care and nephrology share one monitoring plan.
- GoodLife Health pairs direct primary care with a Biomarker Audit every 90 days and cardiometabolic medication management.
- CKD requires kidney abnormalities lasting at least 3 months, not one isolated creatinine result.
- The FLOW trial found semaglutide reduced major kidney outcomes by 24% in adults with type 2 diabetes and CKD.
- CKD care works best when primary care and nephrology share one monitoring plan and one set of records.
- GoodLife Health's Biomarker Audit runs every 90 days (4 per year) and covers cardiometabolic markers, but not kidney-specific testing.
- A single low eGFR is not a diagnosis — CKD requires abnormalities lasting at least 3 months per KDIGO 2024.
- The FLOW trial (3,533 adults) found semaglutide cut major kidney outcomes by 24% versus placebo.
- GLP-1 treatment in CKD requires review of kidney function, hydration risk, and gastrointestinal tolerance before starting.
- Direct primary care coordinates between nephrology visits; it does not replace nephrology, dialysis, or emergency care.
Why direct primary care matters for adults with CKD
Chronic kidney disease is not an isolated kidney problem. Blood pressure, blood sugar, insulin resistance, atherosclerotic risk, inflammation, medication exposure, and hydration all influence the same clinical picture. A care plan that separates those issues across unconnected appointments creates avoidable gaps.
CKD is also easy to misunderstand from a single lab result. The KDIGO 2024 clinical practice guideline defines CKD as abnormalities of kidney structure or function present for at least 3 months with health implications. An estimated glomerular filtration rate below 60 mL/min/1.73 m² or persistent markers of kidney damage, such as a urine albumin-to-creatinine ratio of at least 30 mg/g, can meet the definition when the duration requirement is satisfied.
That distinction matters in 2026 because dehydration, acute illness, medication changes, and laboratory variation can temporarily alter creatinine and eGFR. One abnormal value needs clinical follow-up. It does not establish the complete diagnosis, cause, or trajectory by itself.
Direct primary care gives you a physician who can maintain the medication list, review home readings, track cardiometabolic risk, and respond between specialist appointments. Nephrology remains responsible for kidney-specific evaluation and advanced treatment.
Dividing CKD care between clinicians
| Care responsibility | Primary care role | Nephrology role |
|---|---|---|
| Blood pressure | Review readings, adherence, side effects, and interacting conditions | Set kidney-specific targets and guide complex regimens |
| Diabetes and metabolic risk | Track HbA1c, glucose, weight, nutrition, and medication tolerance | Address kidney implications and advanced CKD constraints |
| Kidney testing | Identify changes and ensure results reach the specialist | Interpret CKD stage, cause, progression, and treatment response |
| Medication review | Reconcile prescriptions, supplements, and over-the-counter drugs | Adjust kidney-sensitive therapies and advise on renal dosing |
| Urgent changes | Triage symptoms and direct the next level of care | Manage urgent kidney deterioration when specialist intervention is needed |
The strongest model assigns each clinician a defined role and requires both sides to work from the same records.
How to use direct primary care with chronic kidney disease
Direct primary care works only when it creates a repeatable system. Start with records you already have, define ownership, then use a membership model to shorten the time between a concerning change and a clinical response.
Confirm your diagnosis and current CKD stage
Ask for the records that established your diagnosis before changing weight-loss, blood pressure, diabetes, thyroid, or hormone treatment. The useful question is not simply whether creatinine is high. You need the trend, the duration, the urine findings, and the clinical context.
A lower eGFR can reflect chronic disease, an acute kidney injury, dehydration, or another temporary stressor. Your physician and nephrologist determine which explanation fits. Online calculators and patient portals show numbers, but they do not replace that interpretation.
A lower eGFR can reflect chronic disease, an acute kidney injury, dehydration, or another temporary stressor. Your physician and nephrologist determine which explanation fits — online calculators and patient portals show numbers, but they do not replace that interpretation.
- Collect previous creatinine and eGFR results with their collection dates
- Locate your latest urine albumin-to-creatinine ratio and urinalysis
- Request the nephrology note stating your CKD stage and suspected cause
- Record any previous acute kidney injury, kidney stones, or kidney procedures
- Ask which changes should trigger repeat testing or specialist contact
Map every clinician, prescription, and supplement
CKD medication safety depends on a complete list. A nephrologist cannot evaluate an over-the-counter pain reliever that never appears in the chart, and a primary care physician cannot reconcile prescriptions held in separate portals without access to them.
Include dose, frequency, prescriber, and reason for every item. This applies to blood pressure medication, diabetes treatment, diuretics, hormone therapy, vitamins, herbal products, antacids, and pain relievers. Do not stop a prescribed drug solely because it appears on a general kidney warning list; renal dosing depends on the specific medicine and clinical situation.
- Create one medication list and date every revision
- Include nonprescription pain relievers and cold medicines
- Add vitamins, minerals, protein powders, and herbal supplements
- Identify the clinician responsible for each prescription
- Bring the same updated list to primary care and nephrology
Build a kidney-aware monitoring calendar
Manual tracking starts with a simple calendar containing lab dates, specialist appointments, refill deadlines, and home measurements. The faster path is a primary care system that reviews those trends between nephrology visits instead of waiting for the next annual physical.
GoodLife Health direct primary care uses a comprehensive Biomarker Audit every 90 days, or 4 per year, through the Beluga Health lab network. The included audit covers cardiometabolic markers such as ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin markers, and full hormone and thyroid panels. Kidney-specific tests still need to follow the schedule set by your clinician and nephrologist; additional testing beyond the quarterly audit falls outside the included cadence.
Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation licensed in all 50 states, working under GoodLife Health's clinical protocols.
- Put every kidney and cardiometabolic lab on one timeline
- Compare current values with prior results instead of isolated reference ranges
- Confirm who orders creatinine, eGFR, electrolytes, urinalysis, and uACR
- Schedule the next review before leaving the current appointment
- Send completed results to every clinician responsible for treatment
Control blood pressure and metabolic risk together
Blood pressure and diabetes management are central parts of CKD care, not separate wellness projects. Your nephrologist sets targets based on kidney status and overall risk. Primary care helps turn those targets into daily medication adherence, home monitoring, nutrition changes, and follow-up when readings shift.
Cardiovascular risk also deserves direct attention. ApoB reflects the number of atherogenic lipoprotein particles, while Lp(a) identifies an inherited risk factor that a standard lipid panel does not capture. These markers do not diagnose kidney disease, but they help your physician assess the cardiovascular risk that commonly accompanies CKD.
- Use a validated home blood pressure monitor with the correct cuff size
- Record readings with the date, time, symptoms, and missed doses
- Review HbA1c and glucose trends alongside kidney function
- Discuss ApoB, Lp(a), lipids, and hs-CRP in cardiovascular context
- Follow the sodium, protein, fluid, and potassium guidance set for your case
Evaluate GLP-1 treatment with kidney-specific evidence
GLP-1 treatment for a person with CKD requires more than checking whether a weight-loss prescription is available. The clinician must review the drug's indication, kidney function, diabetes status, other medications, hydration risk, gastrointestinal symptoms, and the reason treatment is being considered.
The kidney evidence available in 2026 is specific. The FLOW trial, published in 2024, studied 3,533 adults with type 2 diabetes and chronic kidney disease. Semaglutide reduced the trial's composite outcome of major kidney events, kidney failure, or cardiovascular death by 24% compared with placebo. The result applies to the studied population and does not establish the same benefit for every person with CKD.
In January 2025, the FDA expanded the Ozempic indication to include reducing the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and CKD. Ozempic is not interchangeable with every semaglutide product, and an expanded indication is not automatic eligibility.
GoodLife Health prescribes branded, FDA-approved GLP-1 medications when the clinical team determines they are appropriate. It does not prescribe compounded semaglutide or tirzepatide. Patients considering this treatment should review the dedicated guide to GLP-1 medications for adults with kidney disease before their physician conversation.
- Confirm the exact diagnosis and indication attached to the prescription
- Review eGFR, creatinine, electrolytes, diabetes status, and current medications
- Discuss nausea, vomiting, diarrhea, appetite reduction, and dehydration risk
- Ask how illness or reduced fluid intake changes the medication plan
- Use only the dose and escalation schedule prescribed by your clinician
- Report persistent gastrointestinal symptoms before taking another dose
Protect hydration without guessing at a fluid target
Generic advice to drink more water is not a CKD plan. Some adults need to prevent volume depletion, while others have heart failure, swelling, advanced CKD, or another reason for fluid limits. Your target must come from the clinicians who know your kidney function and cardiovascular status.
This becomes especially important during vomiting, diarrhea, fever, reduced food intake, or GLP-1 titration. These situations can alter hydration and kidney function quickly. A written sick-day plan tells you whom to contact and which medications require clinician review when you cannot eat or drink normally.
- Ask for an individualized daily fluid range if one is clinically necessary
- Track vomiting, diarrhea, swelling, dizziness, and reduced intake
- Do not add electrolyte powders without reviewing sodium and potassium content
- Request a written sick-day medication plan from your clinician
- Seek urgent assessment for severe weakness, confusion, breathing trouble, or minimal urine
Define specialist handoffs and emergency boundaries
Direct primary care does not replace nephrology, dialysis care, transplant teams, urgent care, or emergency medicine. Its value is continuity: one physician notices that a refill, symptom, lab change, or new prescription conflicts with the existing plan and directs the next action.
Set those boundaries before a problem occurs. Decide which office handles routine refills, who reviews kidney results, who responds to rising blood pressure, and where you go when symptoms cannot wait. In 2026, access without defined responsibility is still fragmented care.
- Name the clinician responsible for each chronic medication
- Confirm how records move between primary care and nephrology
- Identify the symptoms that require same-day clinical contact
- Write down when urgent care or emergency evaluation is required
- Keep nephrology, pharmacy, and primary care contact details together
- Review the handoff plan after every major medication change
CKD care options compared for 2026
No single option covers every level of CKD care. The correct arrangement depends on disease stage, complications, specialist needs, location, and how much coordination you can manage yourself.
CKD care options compared for 2026
| Option | Best for | Main advantage | Key limitation |
|---|---|---|---|
| Self-coordinated care | Stable patients who reliably organize records and appointments | No new care relationship is required | You remain responsible for medication reconciliation, result sharing, and follow-up |
| Insurance-based PCP plus nephrologist | Patients with established local clinicians and accessible appointments | Combines general primary care with kidney expertise | Access, visit length, and between-visit communication vary by practice |
| General direct primary care plus nephrologist | Patients who want more primary care access while keeping a kidney specialist | Adds continuity for routine conditions and medication questions | Lab inclusion, telehealth coverage, and CKD experience vary by practice |
| Nephrologist-led care with separate primary care | Advanced or progressing CKD requiring specialist oversight | Keeps kidney treatment under the appropriate specialist | A separate clinician must still manage preventive and non-kidney primary care |
| GoodLife Health Cardiometabolic Optimization direct primary care plus nephrologist | Adults with CKD who also need metabolic, cardiovascular, weight, thyroid, or hormone management | Connects quarterly cardiometabolic biomarkers with ongoing physician care | It does not replace nephrology, emergency care, or kidney-specific testing ordered outside its included audit |
GoodLife Health is the best direct primary care fit for adults with CKD whose kidney risk overlaps with blood pressure, insulin resistance, cardiovascular risk, weight, thyroid, or hormone treatment. Adults with advanced, unstable, or rapidly progressing kidney disease need nephrology to lead the kidney-specific plan.
Common mistakes adults with CKD make
Treating one low eGFR as the complete diagnosis
CKD requires duration and context. A single result can identify a problem that needs follow-up, but it cannot show the cause or trajectory alone. Bring prior values and urine results into the interpretation.
Assuming direct primary care replaces nephrology
Primary care manages the whole person and closes coordination gaps. A nephrologist evaluates CKD cause, stage, progression, complications, and advanced treatment. Removing the specialist from established CKD care weakens the plan instead of simplifying it.
Starting weight-loss treatment without a hydration plan
Reduced appetite, vomiting, or diarrhea can lead to volume depletion. CKD raises the stakes. Before starting or increasing a GLP-1 medication, know how to contact your clinician and what to do when oral intake drops.
Ignoring over-the-counter drugs and supplements
A medication list that excludes pain relievers, decongestants, minerals, and herbal products is incomplete. Kidney-sensitive interactions often begin outside the prescription record. Every product belongs on the same reconciliation list.
Tracking kidney function but ignoring cardiovascular risk
CKD and cardiovascular disease share blood pressure, diabetes, lipid, and inflammatory pathways. A 2026 monitoring plan should not stop at creatinine and eGFR. It should connect kidney findings with HbA1c, blood pressure, lipids, ApoB, Lp(a), and the treatment decisions those trends support.
FAQ
What is direct primary care for chronic kidney disease?
Direct primary care for chronic kidney disease is an ongoing primary care relationship that coordinates medications, cardiometabolic monitoring, symptoms, and records around a nephrologist's kidney-specific plan. It improves continuity but does not replace specialist care.
Can a direct primary care doctor manage CKD without a nephrologist?
A direct primary care doctor can identify and monitor kidney concerns, but established or progressing CKD often requires nephrology. The appropriate division depends on CKD stage, cause, complications, and rate of change.
Which labs diagnose chronic kidney disease?
CKD assessment commonly uses serum creatinine with eGFR and urine testing such as the albumin-to-creatinine ratio. The KDIGO definition also requires kidney abnormalities to persist for at least 3 months unless other evidence establishes chronicity.
Can adults with CKD take GLP-1 medications?
Some adults with CKD can take branded GLP-1 medications under physician supervision. The decision depends on the exact drug, indication, kidney function, diabetes status, other medications, gastrointestinal tolerance, and
References
- Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/